SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 9, 2004
NANOGEN, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-23541 | 33-0489621 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 10398 Pacific Center Court, San Diego, California | 92121 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (858) 410-4600
Item 5. Other Events.
On February 10, 2004, Nanogen, Inc. (the “Registrant”) announced that it has signed a definitive agreement to acquire SynX Pharma, Inc., a company organized and existing under the laws of the Province of Ontario. A copy of the press release issued by the Registrant on February 10, 2004 concerning the foregoing transaction is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
| (c) | Exhibits. |
| 99.1 | Press Release of Registrant, dated February 10, 2004, announcing that it has signed a definitive agreement to acquire SynX Pharma, Inc., a company organized and existing under the laws of the Province of Ontario. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NANOGEN, INC. | ||||
| Dated: February 10, 2004 |
By: | /s/ David Ludvigson | ||
| David Ludvigson, | ||||
| Executive Vice President | ||||
| Chief Financial Officer and Treasurer | ||||
EXHIBIT INDEX
| Exhibit Number |
Description of Document | |
| 99.1 | Press Release of Registrant, dated February 10, 2004, announcing that it has signed a definitive agreement to acquire SynX Pharma, Inc., a company organized and existing under the laws of the Province of Ontario. |